Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study2015 · 88 citations
2. 2Circulating microRNAs as markers of liver inflammation, fibrosis and cancer2014 · 121 citations
3. 3Genome-wide identification of circulating-miRNA expression quantitative trait loci reveals the role of several miRNAs in the regulation of cardiometabolic phenotypes2019 · 81 citations
4. 4miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease2016 · 58 citations
5. 5Genome-wide identification of microRNA expression quantitative trait loci2015 · 185 citations